FTO and obesity due to melanocortin 4 receptor deficiency: Several studies have associated various SNPs in the FTO gene with the risk of obesity-associated malignancies (best summarized in [24]), e.g. breast [8,9], endometrial [10,11], and pancreatic cancers [12].